stock
MBX · MBX Biosciences, Inc.
What MBX Biosciences, Inc. reports to the SEC, read from its filings.
Open in the appPrice
The live MBX price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on MBX.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 48,160,096 as of 2026-08-03 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- —
- Net
- —
Returns
- ROE
- -25.5%
- ROA
- -23.9%
Health
- Current ratio
- 18.1x
- Debt/equity
- —
Deep value
- NCAV
- $401.49M
- NCAV per share
- $8.34
- Price/NCAV
- Locked
- NNWC
- $27.75M
- NNWC per share
- $0.58
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue (not reported by this company) | Gross profit (not reported by this company) | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$40.93M | -$37.09M | 10-Q filed 2026-08-06 |
| 2026-03-31 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$27.27M | -$23.52M | 10-Q filed 2026-08-06 Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-12-31 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$25.80M | -$22.09M | 10-Q filed 2026-08-06 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-09-30 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$23.93M | -$21.62M | 10-Q filed 2025-11-06 |
| 2025-06-30 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$21.80M | -$19.41M | 10-Q filed 2026-08-06 |
| 2025-03-31 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$26.53M | -$23.88M | 10-Q filed 2026-08-06 Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-12-31 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$18.61M | -$15.59M | 10-K filed 2026-03-12 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. |
| 2024-09-30 | —Revenue: unreported by this company. | —Gross profit: unreported by this company. | -$19.61M | -$18.14M | 10-Q filed 2025-11-06 |
- Assets
- $435.91M
- Equity
- $409.54M
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | — | -$98.06M | -$87.00M | -$81.88M |
| 2024-12-31 | — | -$68.19M | -$61.92M | -$55.55M |
| 2023-12-31 | — | -$35.31M | -$32.56M | -$32.11M |
Company filings
since Thu Mar 12
events
Regulation FD disclosure, Other event
Regulation FD disclosureOther eventAug 278-KResults, Regulation FD disclosure, Other event
ResultsRegulation FD disclosureOther eventAug 68-KExecutive or director change
Executive or director changeJul 138-KRegulation FD disclosure, Other event
Regulation FD disclosureOther eventJun 128-KExecutive or director change, Shareholder vote results
Executive or director changeShareholder vote resultsJun 58-KRegulation FD disclosure, Other event
Regulation FD disclosureOther eventMay 118-K
5% owners ()
Deep Track Capital, LP
Stake update
Frazier Life Sciences Public Fund, L.P.
Stake update
ORBIMED ADVISORS LLC
Stake update
BlackRock, Inc.
Passive stake
Wellington Management Group LLP
Stake update
Insiders, politicians and funds
Insider trades, last 90 days
Azoulay Salomon
Chief Medical Officer
Sale$24,335Aug 5, 4:57 PM ET
Politician trades, last 90 days
No politician trades filed in the last 90 days.
Funds
None of the tracked funds held this at their last 13F.
News
Stories that named MBX, and the market events around them.
Sign in to see thisBoard
The MBX board could not be loaded.
Retry the MBX boardnakagai
Signals on MBX come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the MBX board